Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current status of interferon therapy].

C Dittrich

    Wiener Medizinische Wochenschrift (1946)
    |April 30, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Interferons (IFN) are effective treatments for various viral diseases and cancers. Further research is needed to confirm efficacy for other conditions, but IFN is a valuable therapeutic option.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reply to the letter to the editor 'Integrating communication as a core skill in the global curriculum for medical oncology' by Horlait et al.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels.

    Case reports in oncology·2014
    Same author

    Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. Preface.

    Onkologie·2013

    Area of Science:

    • Immunology and Virology
    • Oncology
    • Pharmacology

    Context:

    • Interferons (IFN) are known for their antiviral, antiproliferative, and immunomodulatory properties.
    • Despite advancements in gene technology providing ample IFN supply, their precise mechanisms of action require further elucidation.
    • Therapeutic outcomes with IFN vary significantly across different disease types.

    Purpose:

    • To review the established and potential therapeutic applications of interferons (IFN).
    • To identify viral infections and malignancies where IFN has demonstrated proven efficacy.
    • To highlight areas where further clinical investigation is necessary to validate IFN's therapeutic role.

    Summary:

    • IFN has shown therapeutic benefits in viral infections including herpesviruses, cytomegalovirus, chronic hepatitis B, and acute respiratory viruses.

    Related Experiment Videos

  • Established uses include laryngeal papillomatosis, condylomata acuminata, Kaposi's sarcoma in AIDS patients, and hairy cell leukemia.
  • IFN is also effective for certain malignancies like malignant lymphoma, multiple myeloma, melanoma, and hypernephroma, with a primary role in hairy cell leukemia.

    • Impact:

    • IFN is currently a valuable therapeutic agent for specific viral diseases and hematologic/solid tumors.
    • Definitive assessment of IFN efficacy for other indications requires further Phase II and controlled studies.
    • IFN represents a significant advancement in the treatment of complex diseases, enhancing therapeutic options.